BEIJING: An inhalable Covid-19 vaccine developed by CanSino Biologics has been shown to be safe and effective at triggering the production of neutralising antibodies, making it a possible booster shot option that is accessible and painless to administer, a study published in the journal The Lancet Respiratory Medicine said.The vaccine is an aerosol version of Convidecia, a single-dose adenovirus-based viral vector vaccine that was granted emergency use listing by the World Health Organisation (WHO) last week.
It was the 11th Covid-19 vaccine validated by the WHO and was found to have 64% efficacy against symptomatic disease and 92% efficacy against severe Covid-19.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
